Tagged with AMR

Yoshitaka Koketsu – Chairman and CEO, Sumitomo Pharma Group in China
4 Key Priorities for the European Medicines Agency in 2023
AMR Still a Threat To Millions of Lives: WHO
Pharma Industry Taking Lead to Safely Manufacture Antibiotics
Sandoz CEO Richard Saynor on Five Crucial Biosimilars Market Trends
Sweden as a Global Testbed for AMR Incentive Models
Uğur Bingöl – General Manager Turkey, Middle East and Africa, Menarini
Bertrand Ducrey – CEO, Debiopharm
The Pharmaceutical Strategy for Europe – A Game-Changer for the EU?
Why Europe Needs a Sustainable Pharma Manufacturing System
Pierre Meulien – Executive Director, Innovative Medicines Initiative (IMI)
New Billion Dollar Pharma Action Fund to Counter ‘Slow Tsunami’ of Antimicrobial Resistance
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here